PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $54,000 | +38.5% | 15,935 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $39,000 | +8.3% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $36,000 | +5.9% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $34,000 | -35.8% | 15,935 | 0.0% | 0.01% | -33.3% |
| Q3 2016 | $53,000 | +6.0% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $50,000 | -10.7% | 15,935 | 0.0% | 0.01% | -10.0% |
| Q1 2016 | $56,000 | 0.0% | 15,935 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $56,000 | -30.0% | 15,935 | 0.0% | 0.01% | -33.3% |
| Q3 2015 | $80,000 | -21.6% | 15,935 | 0.0% | 0.02% | -11.8% |
| Q2 2015 | $102,000 | -8.9% | 15,935 | 0.0% | 0.02% | -5.6% |
| Q1 2015 | $112,000 | – | 15,935 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |